Literature DB >> 11821945

Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis.

Wei-Ping Lee1, Yong Wen, Brian Varnum, Mien-Chie Hung.   

Abstract

Adenovirus type 5 E1A protein (E1A) associates with anti-tumor activities by reversing the transformed phenotype, inhibiting metastasis, and inducing apoptosis. We have previously identified that E1A suppresses the expression of Axl, a transforming tyrosine kinase and that Axl-Gas6 receptor-ligand interaction prevents E1A transfectants from apoptosis induced by serum deprivation. To determine how the Axl-Gas6 interaction prevents E1A-mediated apoptosis, we analysed the expression of anti-apoptotic molecules and found that the activated form of Akt was suppressed in the E1A transfectant ip 1-E1A and that Gas6 was able to activate Akt in ip 1-E1A cells reexpressing Axl (ip 1-E1A-Axl). To determine whether activated Akt is required to prevent E1A-mediated apoptosis, ip 1-E1A-Axl cells were treated with the phosphatidylinositol-3'-OH kinase inhibitor wortmannin or transfected with a dominant negative Akt mutant. In both cases, Gas6 no longer protected the cells from serum deprivation-induced apoptosis. Thus, we conclude that activated Akt is required for Axl-Gas6 signaling to prevent E1A-mediated apoptosis induced by serum deprivation. Downstream molecules of Akt, including NF-kappaB, Fas ligand, and BAD were examined, among which phosphorylation of BAD by Axl-Gas6 signaling is associated with the anti-apoptotic activity of Akt in our study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821945     DOI: 10.1038/sj.onc.1205066

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Lutz Thon; Uwe Mamat; Paola Bellosta; Claudio Basilico; Dieter Adam; Ralf Paus; Silvia Bulfone-Paus
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

Review 2.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

3.  Function of Axl receptor tyrosine kinase in non-small cell lung cancer.

Authors:  Guoan Zhang; Meng Wang; Hongli Zhao; Wen Cui
Journal:  Oncol Lett       Date:  2017-12-27       Impact factor: 2.967

4.  The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.

Authors:  Alvarez Hector; Elizabeth A Montgomery; Collins Karikari; Marcia Canto; Kerry B Dunbar; Jean S Wang; Georg Feldmann; Seung-Mo Hong; Michael C Haffner; Alan K Meeker; Sacha J Holland; Jiaxin Yu; Thilo J Heckrodt; Jing Zhang; Pingyu Ding; Dane Goff; Rajinder Singh; Juan Carlos Roa; Arivusudar Marimuthu; Gregory J Riggins; James R Eshleman; Barry D Nelkin; Akhilesh Pandey; Anirban Maitra
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

5.  The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.

Authors:  J D Paccez; G J Vasques; R G Correa; J F Vasconcellos; K Duncan; X Gu; M Bhasin; T A Libermann; L F Zerbini
Journal:  Oncogene       Date:  2012-03-12       Impact factor: 9.867

Review 6.  Growth arrest-specific gene 6 (gas6) and vascular hemostasis.

Authors:  Sandrine Laurance; Catherine A Lemarié; Mark D Blostein
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 7.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

8.  Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis.

Authors:  Yong Liao; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 9.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

10.  Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.

Authors:  Lin Pao-Chun; Perry M Chan; Wing Chan; Ed Manser
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.